TrialNature medicine2026

Survodutide in adults with obesity and metabolic dysfunction-associated steatotic liver disease: SYNCHRONIZE-MASLD, a randomized, double-blind, placebo-controlled phase 3 trial.

Lee M Kaplan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.